astriatx.com (ATXS) Company Sales Volume

Astria Therapeutics Inc - graphic logo of issuer ATXS

Astria Therapeutics (ATXS) combines strict financial control in the development of STAR-0215 with the implementation of automated biomolecule screening systems. The company's sales volume confirms the dynamics of these processes, where the current parameter equals 0.00. This development strategy relies on close cooperation with scientific centers to rapidly bring new immunological drugs to market.

ATXS Astria Pharma: Revenue and Sales Volume in the range 07/04/2022 - 02/07/2026

Analytical breakdowns for Astria Therapeutics, Inc. (ATXS)

- price and consensus price forecast:
Comprehensive company analysis:Astria Therapeutics - ATXS
Manufactured product of astriatx.com

For the biotech sector, revenue monitoring serves as a key indicator of a development's commercial viability. The current sales dynamics of Astria Therapeutics (ATXS) capture daily cash inflows, reflecting real market demand for products. Growth in this metric confirms operational resilience and management efficiency. For Astria Therapeutics (ATXS), this metric will validate the success of the strategy to implement the STAR-0215 drug. A steady increase in revenue will prove the demand for the therapy featuring a quarterly injection cycle.

Key competitors

Revenue and Sales Volume argenx.com|Company Revenue BioNTech Group (BNTX)|Abivax S.A. - Company Sales Volume|Revenue and Sales Volume ADMA (admabiologics.com)|Protagonist Corp (PTGX) - Company Total Revenue|immunovant.com - Revenue and Sales Volume|KNSA - Revenue and Sales Volume|Grifols (GRFS) - Company Revenue|Company Sales Volume ADPT|Company Revenue Celldex|AUPH: Company Sales Revenue|Revenue and Sales Volume BCRX|Revenue and Sales Volume Vera Therapeutics (VERA)|Dianthus Therapeutics - Company Sales|Pharvaris - Company Revenue|ABCL - Company Revenue|TRML - Revenue and Sales Volume|PGEN: Revenue and Sales Volume|Company Sales Volume PHAR|Company Sales NKTR|UPB: Company Sales Revenue|Company Revenue zenasbio.com (ZBIO)|IMNM (Immunome Corp) - Company Sales Revenue|Revenue and Sales Volume GOSS (Gossamer Bio, Inc.)|KALV (KalVista Pharmaceuticals) - Company Annual Revenue|SEPN - Company Revenue|Company Sales Revenue PVLA (Pieris Pharma)|Savara Pharma (SVRA) - Company Revenue|Rigel Pharmaceuticals Inc (RIGL) - Revenue and Sales Volume|Company Revenue AnaptysBio|Company Sales Volume ENGN (enGene Holdings Inc.)|Company Sales RAPT (RAPT Therapeutics, Inc.)|Revenue and Sales Volume Aerovate Therapeutics, Inc. (JBIO)|Revenue and Sales Volume ACRS (aclaristx.com)|Kyverna Therapeutics (KYTX) - Company Total Revenue|tizianalifesciences.com - Revenue and Sales Volume|CABA (Cabaletta Bio, Inc.) - Company Sales Volume|VTYX: Revenue and Sales Volume|THTX - Company Gross Revenue|Company Revenue Avalo Therapeutics Inc|Eledon (ELDN) - Company Gross Revenue|Company Revenue agenusbio.com (AGEN)|CLYM (Climb Bio Inc) - Company Sales Revenue|Revenue and Sales Volume ZURA (zurabio.com)|Company Sales Revenue ATYR|ADAG - Company Revenue|ikenaoncology.com (IMA) - Company Sales|Shattuck Labs (STTK) - Company Revenue|EQ - Company Gross Revenue|CNTB (connectbiopharm.com) - Revenue and Sales Volume|IMUX: Company Sales Revenue|Company Revenue Atara Biotherapeutics, Inc. (ATRA)|Company Gross Revenue InflaRx NV|Revenue and Sales Volume XFOR (X4 Pharmaceuticals)|Revenue and Sales Volume Adicet Bio ACET|CELU: Company Sales|Company Sales Revenue INMB (INmune Bio)|Barinthus Bio (BRNS) - Company Revenue|Kezar Life Sciences (KZR) - Revenue and Sales Volume|Company Revenue sabbiotherapeutics.com|Revenue and Sales Volume Akari Therapeutics Plc|Company Revenue Enlivex Therapeutics Ltd (ENLV)|Q32 Bio Corp (QTTB) - Company Total Sales Volume|Company Revenue GeoVax Corp GOVX|Company Gross Revenue Edesa Biotech Corp (EDSA)|IBIO: Company Sales|Company Sales Revenue CARM (carismatx.com)|XTLB: Revenue and Sales Volume|BOLT - Company Gross Revenue|Company Sales HCWB|Company Sales Aptevo Therapeutics Inc. (APVO)|Revenue and Sales Volume AIM|ADTX: Company Annual Revenue|GRI Bio - Company Sales|Company Gross Revenue XORTX Therapeutics Inc (XRTX)|HIND: Company Sales|Revelation Biosciences (REVB) - Company Sales|Indaptus Therapeutics, Inc. (INDP) - Company Revenue|SCNI - Company Gross Revenue|CALI (CalciMedica) - Revenue and Sales Volume|Revenue and Sales Volume affimed.com|Company Revenue Allakos Therapeutics (ALLK)|HOOK - Company Total Revenue|Company Revenue IGM Biosciences, Inc. IGMS|Company Gross Revenue iTeos Therapeutics, Inc. (ITOS)|Ocean Biomedical Corp - Revenue and Sales Volume|TC BioPharm (TCBP) - Company Sales|THRD: Revenue and Sales Volume